Authors: Wikell, C Kugelberg, FC Hjorth, S Apelqvist, G Bengtsson, F

Citation: C. Wikell et al., Effect of halving the dose of venlafaxine to adjust for putative pharmacokinetic and pharmacodynamic changes in an animal model of chronic hepatic encephalopathy, CLIN NEUROP, 24(6), 2001, pp. 324-333

Authors: Kugelberg, FC Apelqvist, G Carlsson, B Ahlner, J Bengtsson, F

Citation: Fc. Kugelberg et al., In vivo steady-state pharmacokinetic outcome following clinical and toxic doses of racemic citalopram to rats, BR J PHARM, 132(8), 2001, pp. 1683-1690

Authors: Wikell, C Apelqvist, G Carlsson, B Hjorth, S Bergqvist, PBF Kugelberg, FC Ahlner, J Bengtsson, F

Citation: C. Wikell et al., Pharmacokinetic and pharmacodynamic responses to chronic administration ofthe selective serotonin reuptake inhibitor citalopram in rats, CLIN NEUROP, 22(6), 1999, pp. 327-336